Immediate Impact
65 standout
Citing Papers
Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
Three-year outcomes of post-acute sequelae of COVID-19
2024 Standout
Works of Andreas Lind being referenced
EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection
2022
Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Andreas Lind | 201 | 80 | 69 | 90 | 82 | 32 | 374 | |
| Vijay Harypursat | 274 | 30 | 106 | 70 | 49 | 39 | 419 | |
| Alessandra Vergori | 268 | 37 | 92 | 82 | 73 | 47 | 452 | |
| Jesper Damsgaard Gunst | 254 | 106 | 46 | 155 | 66 | 26 | 439 | |
| Pilar Vizcarra | 270 | 34 | 62 | 64 | 48 | 45 | 367 | |
| Zeinab Mohseni Afshar | 191 | 46 | 81 | 80 | 22 | 49 | 446 | |
| Annalisa Mondi | 237 | 31 | 57 | 48 | 95 | 24 | 350 | |
| Kathleen E. Singer | 94 | 40 | 122 | 44 | 54 | 28 | 425 | |
| Luciana Lepore | 255 | 32 | 58 | 81 | 30 | 21 | 425 | |
| Federica Frasca | 160 | 85 | 65 | 64 | 20 | 41 | 341 | |
| Santhamani Ramasamy | 207 | 77 | 72 | 82 | 34 | 24 | 385 |
All Works
Login with ORCID to disown or claim papers
Loading papers...